52 results
S-8
EX-99.1
GYRE
Gyre Therapeutics Inc
30 Oct 23
Registration of securities for employees
5:46pm
, the Grantee’s name, account information, social security number, tax number and contact information. The Company may process such personal data in its
8-K
EX-10.2
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
, the Grantee’s name, account information, social security number, tax number and contact information. The Company may process such personal data in its
8-K
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
of professor-level senior engineer from Zhejiang Province Human Resources and Social Security Department in June 2015.
Han Ying, Ph.D. (Age 58). Dr. Ying
8-K
EX-14.1
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
the intellectual property rights of others. We strongly encourage all directors, officers and employees to avoid references to the Company on social
DEFM14A
9cdxg6lc
20 Jul 23
Proxy related to merger
8:57am
PRER14A
52hhjaogggh2 y3nubb
15 May 23
Preliminary revised proxy
4:02pm
PREM14A
w4s td359p5ctzbnof9q
30 Mar 23
Preliminary proxy related to merger
4:48pm
425
EX-2.1
khj9 tm7z
27 Dec 22
Business combination disclosure
7:02am
425
EX-2.2
x9iq51l bpi
27 Dec 22
Business combination disclosure
7:02am
8-K
EX-2.1
c0fjc61bp ki09t30
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
8-K
EX-2.2
ctbblsc1cq7nd8oje
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
DEFC14A
brusmftiez
20 Jul 22
Proxy in contested solicitation
9:16am
DEFC14A
39gaf fcaag0rwr51
19 Jul 22
Proxy in contested solicitation
8:01am
PRRN14A
9iqjhtkpdxpob3
18 Jul 22
Revised preliminary proxy statement filed by non-management
5:07pm
PRRN14A
2ci71
14 Jul 22
Revised preliminary proxy statement filed by non-management
5:21pm
PREC14A
te0k8tnq58 jo6z
8 Jul 22
Preliminary proxy with contested solicitation
3:51pm